Services / Lab Panel
Longevity Lab Panel
Comprehensive blood diagnostics designed to uncover what standard labs miss. Every result is physician-reviewed, and yours to keep. No hidden panels, no selective reporting, no gatekeeping — your blood tells a story and you deserve the complete picture.
Longevity Lab Panel
100+ biomarkers
Comprehensive blood panel — metabolic, endocrine, inflammatory, nutritional, immunological, and urinary biomarkers. This is the lab panel included in Your Longevity Report Card. Research participation is required for all services.
$650 | Included in Report Card ($3,750)
Test Name
Hormones & Endocrine
Cortisol, AM
DHEA Sulfate
Estradiol
IGF-1
Insulin
Progesterone
Prolactin
Testosterone, Free, Bioavailable, and Total
SHBG
Thyroid
TSH
Free T4
Free T3
FSH and LH
Cardiovascular & Lipids
Apolipoprotein B
Total Cholesterol
HDL Cholesterol
LDL Cholesterol
Triglycerides
Cholesterol/HDL Ratio
Lipoprotein (a)
Inflammation
C-Reactive Protein (CRP)
High-Sensitivity CRP (hs-CRP)
Sed Rate (ESR)
Uric Acid
Nutrients & Minerals
Vitamin D3 (Calcitriol)
Folate (B9)
Iron, Total
Iron Binding Capacity (TIBC)
Iron Saturation %
Ferritin
Magnesium
Vitamin B12
Metabolic & Organ Function
Creatine Kinase (CK)
Cystatin C
Estimated GFR (Cystatin C)
Hemoglobin A1c
Urine Protein
Urine Creatinine
Protein/Creatinine Ratio
Urinalysis, Complete
Immunology
CD3+ T Cells (% and Absolute)
Estimated GFR (Cystatin C)
CD8+ Suppressor T Cells (% and Absolute)
CD4/CD8 Ratio
NK Cells (CD16+CD56) (% and Absolute)
CD19+ B Cells (% and Absolute)
Absolute Lymphocytes
Toxicology
Arsenic
Lead
Mercury
Foundational Panels
Comprehensive Metabolic Panel
CBC with Differential and Platelets
Galleri Multi-Cancer Early Detection
50+ cancer types
A blood-based multi-cancer early detection test by GRAIL. With a simple blood draw, Galleri can detect a signal shared by more than 50 types of cancer — many of which have no recommended screening tests today — and predict where in the body the cancer signal is located.
$950
Who is appropriate for the Galleri test?
Recommended for adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test should be used in addition to routine cancer screening tests recommended by a healthcare provider. Not recommended for individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Cancer types screened
In clinical studies, the following cancers were diagnosed after a Cancer Signal Detected result.
GI & Digestive
Colon and Rectum
Esophagus
Gallbladder
Liver
Oral Cavity
Pancreas
Small Intestine
Stomach
Ampulla of Vater
Appendix
Anus
GI Stromal Tumor
Gynecologic & Breast
Breast
Cervix
Ovary, Fallopian Tube, Peritoneum
Uterus, Carcinoma
Uterus, Sarcoma
Vagina
Vulva
Gestational Trophoblastic Neoplasms
Urologic
Bladder
Kidney
Prostate
Testis
Penis
Ureter, Renal Pelvis
Blood & Lymphatic
Leukemia
Lymphoma (Hodgkin & Non-Hodgkin)
Plasma Cell Myeloma & Plasma Cell Disorders
Head, Neck & Lung
Lung
Larynx
Nasal Cavity & Nasopharynx
Oropharynx (HPV+)
Oropharynx & Hypopharynx
Mesothelioma
Skin & Soft Tissue
Melanoma
Merkel Cell Carcinoma
Soft Tissue Sarcoma (Abdomen & Thoracic)
Soft Tissue Sarcoma (Head & Neck)
Soft Tissue Sarcoma (Retroperitoneum)
Soft Tissue Sarcoma (Trunk & Extremities)
Soft Tissue Sarcoma (Other)
Endocrine & Other
Adrenal Cortical Carcinoma
Bone
Neuroendocrine (Appendix)
Neuroendocrine (Colon & Rectum)
Neuroendocrine (Pancreas)
Bile Ducts (Distal, Intrahepatic, Perihilar)
The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test has not been cleared or approved by the FDA. The GRAIL clinical laboratory is certified under CLIA and accredited by CAP.
All lab samples drawn at Longevity Metrics and processed through Quest Diagnostics (CLIA-certified, CAP-accredited). Galleri testing processed by GRAIL (CLIA-certified, CAP-accredited). Every result is physician-reviewed before delivery.